Stock Institutional Ownership and Shareholders

SecurityAFMD / Affimed N.V. (N01045108)
Institutional Owners35
Institutional Shares18,095,774
Institutional Value$ 40,597,000 USD

Affimed N.V. (NASDAQ:AFMD) has 35 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,095,774 shares. Largest shareholders include Wellington Management Group Llp, NEA Management Company, LLC, Brookside Capital Management Llc, Tekla Capital Management LLC, Perceptive Advisors Llc, Nationwide Fund Advisors, Baker Brothers Advisors LP, Orbimed Advisors Llc, Telemetry Investments, L.L.C., and Point72 Asset Management, L.P..



Affimed N.V. (NASDAQ:AFMD) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2018-01-10 13F-HR SIMPLEX TRADING, LLC Call 240 8 -96.67 12 0 -100.00
2017-11-14 13F-HR MORGAN STANLEY 100 0 -100.00 0 0
2017-11-13 13F-HR DIMENSIONAL FUND ADVISORS LP 15,010 137,783 817.94 31 310 900.00
2017-11-14 13F-HR BROOKSIDE CAPITAL MANAGEMENT LLC 3,209,013 3,209,013 0.00 6,578 7,220 9.76
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 49 49 0.00 3 6 100.00
2017-11-14 13F-HR Point72 Asset Management, L.P. 292,631 658
2017-11-15 13F-HR GROUP ONE TRADING, L.P. 11,600 4,381 -62.23 24 10 -58.33
2017-11-02 13F-HR/A-1 Advisor Group, Inc. 519 0 -100.00 1 0 -100.00
2017-08-07 13F-HR Parallel Advisors, LLC 15,000 0 -100.00 33 0 -100.00
2017-11-14 13F-HR ROYAL BANK OF CANADA 500 500 0.00 1 1 0.00
2017-11-14 13F-HR MILLENNIUM MANAGEMENT LLC 0 70,002 0 158
2017-11-09 13F-HR WELLS FARGO & COMPANY/MN 30,103 53,766 78.61 62 121 95.16
2017-11-14 13F-HR DEUTSCHE BANK AG\ 0 79,001 0 177
2017-11-14 13F-HR PERCEPTIVE ADVISORS LLC 668,214 1,503
2017-11-14 13F-HR Tower Research Capital LLC (TRC) 100 1,185 1,085.00 0 3
2017-11-14 13F-HR ORBIMED ADVISORS LLC 1,799,700 326,650 -81.85 3,689 735 -80.08
2017-11-14 13F-HR A.R.T. Advisors, LLC 23,800 0 -100.00 48 0 -100.00
2017-11-14 13F-HR BARCLAYS PLC 13,385 13,385 0.00 27 30 11.11
2018-01-10 13F-HR SIMPLEX TRADING, LLC 0 1,612 0 2
2017-11-13 13F-HR WELLINGTON MANAGEMENT GROUP LLP 5,394,386 5,771,526 6.99 11,059 12,985 17.42
2017-11-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 3,000 3,000 0.00 6 7 16.67
2017-11-13 13F-HR MUHLENKAMP & CO INC 72,786 62,535 -14.08 149 141 -5.37
2017-11-14 13F-HR Moore Capital Management, LP 250,000 250,000 0.00 513 563 9.75
2017-10-24 13F-HR TCI Wealth Advisors, Inc. 500 500 0.00 1 1 0.00
2017-11-17 13F-HR/A-1 Virtu Financial LLC 14,676 33
2017-11-13 13F-HR US BANCORP \DE\ 24,000 54
2017-11-14 13F-HR GROUP ONE TRADING, L.P. Put 19,400 0 -100.00 40 0 -100.00
2017-11-14 13F-HR Telemetry Investments, L.L.C. 367,067 312,900 -14.76 752 704 -6.38
2017-11-09 13F-HR JP Morgan Chase & Co 3,733 33,300 792.04 7 70 900.00
2017-11-03 13F-HR NEA Management Company, LLC 3,888,888 3,888,888 0.00 7,972 8,750 9.76
2017-11-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 45,745 0 -100.00 94 0 -100.00
2018-01-12 13F-HR Advocacy Wealth Management Services, LLC 1,000 1,000 0.00 2 1 -50.00
2017-11-14 13F-HR UBS Group AG 2,858 2,062 -27.85 6 5 -16.67
2017-11-13 13F-HR Tekla Capital Management LLC 1,405,324 1,405,324 0.00 2,881 3,162 9.75
2017-10-23 13F-HR Nationwide Fund Advisors 506,199 506,199 0.00 1,038 1,139 9.73
2017-11-15 13F-HR GROUP ONE TRADING, L.P. Call 1,500 1,000 -33.33 3 2 -33.33
2017-11-14 13F-HR DAFNA Capital Management LLC 92,500 0 -100.00 190 0 -100.00
2017-11-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 18,764 18,764 0.00 38 42 10.53
2017-11-14 13F-HR GOLDMAN SACHS GROUP INC 39,326 29,904 -23.96 81 67 -17.28
2018-01-16 13F-HR BANK OF MONTREAL /CAN/ 0 34 0 0
2017-10-31 13F-HR WEDBUSH SECURITIES INC 22,000 0 -100.00 45 0 -100.00
2017-11-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 175,000 175,000 0.00 359 394 9.75
2017-11-14 13F-HR Baker Brothers Advisors LP 400,000 400,000 0.00 820 900 9.76
2018-01-17 13F-HR Creative Planning 95,000 100,000 5.26 214 130 -39.25
2017-08-11 13F-HR KCG HOLDINGS, INC. 0 70,439 0 144
2017-11-13 13F-HR Renaissance Technologies LLC 0 167,600 0 377
2017-10-26 13F-HR Acrospire Investment Management LLC 658 0 -100.00 1 0 -100.00
2017-08-14 13F-HR Frigate Ventures LP 140,500 0 -100.00 323 0 -100.00

Stock Research Report

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an innovative approach to cancer treatment that seeks to harness the body’s own immune defenses to fight tumor cells. The most potent cells of the human defense arsenal are types of white blood cells called Natural Killer cells, or NK-cells, and T-cells. Its proprietary, next-generation bispecific antibodies, which it call TandAbs because of their tandem antibody structure, are designed to direct and establish a bridge between either NK-cells or T-cells and cancer cells. The company TandAbs have the ability to bring NK-cells or T-cells into proximity and trigger a signal cascade that leads to the destruction of cancer cells. Due to their novel tetravalent architecture (which provides for four binding domains), its TandAbs bind to their targets with high affini...

Click for full article
CUSIP: N01045108